Molecular imaging of bone marrow mononuclear cell homing and engraftment in ischemic myocardium

Ahmad Y. Sheikh, Shu An Lin, Feng Cao, Yuan Cao, Koen E A Van Der Bogt, Pauline Chu, Ching-Pin Chang, Christopher H. Contag, Robert C. Robbins, Joseph C. Wu

Research output: Contribution to journalArticle

109 Citations (Scopus)

Abstract

Bone marrow mononuclear cell (BMMC) therapy shows promise as a treatment for ischemic heart disease. However, the ability to monitor long-term cell fate remains limited. We hypothesized that molecular imaging could be used to track stem cell homing and survival after myocardial ischemia-reperfusion (I/R) injury. We first harvested donor BMMCs from adult male L2G85 transgenic mice constitutively expressing both firefly luciferase (Fluc) and enhanced green fluorescence protein reporter gene. Fluorescence-activated cell sorting analysis revealed ∼0.07% of the population to consist of classic hematopoietic stem cells (lin-, thy-int, c-kit+, Sca-1+). Afterward, adult female FVB recipients (n = 38) were randomized to sham surgery or acute I/R injury. Animals in the sham (n = 16) and I/R (n = 22) groups received 5 × 106 of the L2G85-derived BMMCs via tail vein injection. Bioluminescence imaging (BLI) was used to track cell migration and survival in vivo for 4 weeks. BLI showed preferential homing of BMMCs to hearts with I/R injury compared with sham hearts within the first week following cell injection. Ex vivo analysis of explanted hearts by histology confirmed BLI imaging results, and quantitative real-time polymerase chain reaction (for the male Sry gene) further demonstrated a greater number of BMMCs in hearts with I/R injury compared with the sham group. Functional evaluation by echocardiography demonstrated a trend toward improved left ventricular fractional shortening in animals receiving BMMCs. Taken together, these data demonstrate that molecular imaging can be used to successfully track BMMC therapy in murine models of heart disease. Specifically, we have demonstrated that systemically delivered BMMCs preferentially home to and are retained by injured myocardium.

Original languageEnglish (US)
Pages (from-to)2677-2684
Number of pages8
JournalStem Cells
Volume25
Issue number10
DOIs
StatePublished - Oct 2007
Externally publishedYes

Fingerprint

Molecular Imaging
Reperfusion Injury
Bone Marrow Cells
Myocardium
Cell- and Tissue-Based Therapy
Myocardial Ischemia
Cell Survival
sry Genes
Firefly Luciferases
Myocardial Reperfusion Injury
Injections
Hematopoietic Stem Cells
Reporter Genes
Transgenic Mice
Reperfusion
Cell Movement
Echocardiography
Tail
Real-Time Polymerase Chain Reaction
Veins

Keywords

  • Bone marrow
  • Cell homing
  • Heart diseases
  • Molecular imaging

ASJC Scopus subject areas

  • Cell Biology

Cite this

Sheikh, A. Y., Lin, S. A., Cao, F., Cao, Y., Van Der Bogt, K. E. A., Chu, P., ... Wu, J. C. (2007). Molecular imaging of bone marrow mononuclear cell homing and engraftment in ischemic myocardium. Stem Cells, 25(10), 2677-2684. https://doi.org/10.1634/stemcells.2007-0041

Molecular imaging of bone marrow mononuclear cell homing and engraftment in ischemic myocardium. / Sheikh, Ahmad Y.; Lin, Shu An; Cao, Feng; Cao, Yuan; Van Der Bogt, Koen E A; Chu, Pauline; Chang, Ching-Pin; Contag, Christopher H.; Robbins, Robert C.; Wu, Joseph C.

In: Stem Cells, Vol. 25, No. 10, 10.2007, p. 2677-2684.

Research output: Contribution to journalArticle

Sheikh, AY, Lin, SA, Cao, F, Cao, Y, Van Der Bogt, KEA, Chu, P, Chang, C-P, Contag, CH, Robbins, RC & Wu, JC 2007, 'Molecular imaging of bone marrow mononuclear cell homing and engraftment in ischemic myocardium', Stem Cells, vol. 25, no. 10, pp. 2677-2684. https://doi.org/10.1634/stemcells.2007-0041
Sheikh, Ahmad Y. ; Lin, Shu An ; Cao, Feng ; Cao, Yuan ; Van Der Bogt, Koen E A ; Chu, Pauline ; Chang, Ching-Pin ; Contag, Christopher H. ; Robbins, Robert C. ; Wu, Joseph C. / Molecular imaging of bone marrow mononuclear cell homing and engraftment in ischemic myocardium. In: Stem Cells. 2007 ; Vol. 25, No. 10. pp. 2677-2684.
@article{e69569a526a74b3fa13eb6659fee0fca,
title = "Molecular imaging of bone marrow mononuclear cell homing and engraftment in ischemic myocardium",
abstract = "Bone marrow mononuclear cell (BMMC) therapy shows promise as a treatment for ischemic heart disease. However, the ability to monitor long-term cell fate remains limited. We hypothesized that molecular imaging could be used to track stem cell homing and survival after myocardial ischemia-reperfusion (I/R) injury. We first harvested donor BMMCs from adult male L2G85 transgenic mice constitutively expressing both firefly luciferase (Fluc) and enhanced green fluorescence protein reporter gene. Fluorescence-activated cell sorting analysis revealed ∼0.07{\%} of the population to consist of classic hematopoietic stem cells (lin-, thy-int, c-kit+, Sca-1+). Afterward, adult female FVB recipients (n = 38) were randomized to sham surgery or acute I/R injury. Animals in the sham (n = 16) and I/R (n = 22) groups received 5 × 106 of the L2G85-derived BMMCs via tail vein injection. Bioluminescence imaging (BLI) was used to track cell migration and survival in vivo for 4 weeks. BLI showed preferential homing of BMMCs to hearts with I/R injury compared with sham hearts within the first week following cell injection. Ex vivo analysis of explanted hearts by histology confirmed BLI imaging results, and quantitative real-time polymerase chain reaction (for the male Sry gene) further demonstrated a greater number of BMMCs in hearts with I/R injury compared with the sham group. Functional evaluation by echocardiography demonstrated a trend toward improved left ventricular fractional shortening in animals receiving BMMCs. Taken together, these data demonstrate that molecular imaging can be used to successfully track BMMC therapy in murine models of heart disease. Specifically, we have demonstrated that systemically delivered BMMCs preferentially home to and are retained by injured myocardium.",
keywords = "Bone marrow, Cell homing, Heart diseases, Molecular imaging",
author = "Sheikh, {Ahmad Y.} and Lin, {Shu An} and Feng Cao and Yuan Cao and {Van Der Bogt}, {Koen E A} and Pauline Chu and Ching-Pin Chang and Contag, {Christopher H.} and Robbins, {Robert C.} and Wu, {Joseph C.}",
year = "2007",
month = "10",
doi = "10.1634/stemcells.2007-0041",
language = "English (US)",
volume = "25",
pages = "2677--2684",
journal = "Stem Cells",
issn = "1066-5099",
publisher = "AlphaMed Press",
number = "10",

}

TY - JOUR

T1 - Molecular imaging of bone marrow mononuclear cell homing and engraftment in ischemic myocardium

AU - Sheikh, Ahmad Y.

AU - Lin, Shu An

AU - Cao, Feng

AU - Cao, Yuan

AU - Van Der Bogt, Koen E A

AU - Chu, Pauline

AU - Chang, Ching-Pin

AU - Contag, Christopher H.

AU - Robbins, Robert C.

AU - Wu, Joseph C.

PY - 2007/10

Y1 - 2007/10

N2 - Bone marrow mononuclear cell (BMMC) therapy shows promise as a treatment for ischemic heart disease. However, the ability to monitor long-term cell fate remains limited. We hypothesized that molecular imaging could be used to track stem cell homing and survival after myocardial ischemia-reperfusion (I/R) injury. We first harvested donor BMMCs from adult male L2G85 transgenic mice constitutively expressing both firefly luciferase (Fluc) and enhanced green fluorescence protein reporter gene. Fluorescence-activated cell sorting analysis revealed ∼0.07% of the population to consist of classic hematopoietic stem cells (lin-, thy-int, c-kit+, Sca-1+). Afterward, adult female FVB recipients (n = 38) were randomized to sham surgery or acute I/R injury. Animals in the sham (n = 16) and I/R (n = 22) groups received 5 × 106 of the L2G85-derived BMMCs via tail vein injection. Bioluminescence imaging (BLI) was used to track cell migration and survival in vivo for 4 weeks. BLI showed preferential homing of BMMCs to hearts with I/R injury compared with sham hearts within the first week following cell injection. Ex vivo analysis of explanted hearts by histology confirmed BLI imaging results, and quantitative real-time polymerase chain reaction (for the male Sry gene) further demonstrated a greater number of BMMCs in hearts with I/R injury compared with the sham group. Functional evaluation by echocardiography demonstrated a trend toward improved left ventricular fractional shortening in animals receiving BMMCs. Taken together, these data demonstrate that molecular imaging can be used to successfully track BMMC therapy in murine models of heart disease. Specifically, we have demonstrated that systemically delivered BMMCs preferentially home to and are retained by injured myocardium.

AB - Bone marrow mononuclear cell (BMMC) therapy shows promise as a treatment for ischemic heart disease. However, the ability to monitor long-term cell fate remains limited. We hypothesized that molecular imaging could be used to track stem cell homing and survival after myocardial ischemia-reperfusion (I/R) injury. We first harvested donor BMMCs from adult male L2G85 transgenic mice constitutively expressing both firefly luciferase (Fluc) and enhanced green fluorescence protein reporter gene. Fluorescence-activated cell sorting analysis revealed ∼0.07% of the population to consist of classic hematopoietic stem cells (lin-, thy-int, c-kit+, Sca-1+). Afterward, adult female FVB recipients (n = 38) were randomized to sham surgery or acute I/R injury. Animals in the sham (n = 16) and I/R (n = 22) groups received 5 × 106 of the L2G85-derived BMMCs via tail vein injection. Bioluminescence imaging (BLI) was used to track cell migration and survival in vivo for 4 weeks. BLI showed preferential homing of BMMCs to hearts with I/R injury compared with sham hearts within the first week following cell injection. Ex vivo analysis of explanted hearts by histology confirmed BLI imaging results, and quantitative real-time polymerase chain reaction (for the male Sry gene) further demonstrated a greater number of BMMCs in hearts with I/R injury compared with the sham group. Functional evaluation by echocardiography demonstrated a trend toward improved left ventricular fractional shortening in animals receiving BMMCs. Taken together, these data demonstrate that molecular imaging can be used to successfully track BMMC therapy in murine models of heart disease. Specifically, we have demonstrated that systemically delivered BMMCs preferentially home to and are retained by injured myocardium.

KW - Bone marrow

KW - Cell homing

KW - Heart diseases

KW - Molecular imaging

UR - http://www.scopus.com/inward/record.url?scp=35348826634&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35348826634&partnerID=8YFLogxK

U2 - 10.1634/stemcells.2007-0041

DO - 10.1634/stemcells.2007-0041

M3 - Article

VL - 25

SP - 2677

EP - 2684

JO - Stem Cells

JF - Stem Cells

SN - 1066-5099

IS - 10

ER -